Lincoln Pharmaceuticals informs about updates

02 Jul 2025 Evaluate
Pursuant to Regulation 30 of the SEBI Listing Regulations, Lincoln Pharmaceuticals has informed that the new manufacturing facility of the Company located at Block No-176, Trimul Estate, Khatraj, Dis-Gandhinagar, Gujarat has successfully completed its trial run. Further, the facility is expected to commence the commercial production of APIs (Active Pharmaceutical Ingredients) within 1 to 2 years depending upon additional product permission received from Food & Drugs Control Administration. Disclosures required under Regulation 30 read with Schedule III of the SEBI Listing Regulations read along with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November, 2024, SEBI Circular No. SEBI/HO/CFD/CFDPoD-2/P/CIR/2025/25 dated 25th February, 2025 (SEBI Circulars) read with Industry Standards Note on Regulation 30 of the SEBI Listing Regulations, is enclosed as ‘Form A’.

The above information is a part of company’s filings submitted to BSE.

Lincoln Pharma Share Price

480.35 -0.05 (-0.01%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×